Scarica l'app Stockscreener
0.373
9.47%
-0.039
Dopo l'orario di chiusura:
.37
-0.003
-0.80%
Precedente Chiudi:
$0.412
Aprire:
$0.3963
Volume 24 ore:
1.09M
Relative Volume:
0.07
Capitalizzazione di mercato:
$9.02M
Reddito:
-
Utile/perdita netta:
$-125.52M
Rapporto P/E:
-0.0494
EPS:
-7.5468
Flusso di cassa netto:
$-5.72M
1 W Prestazione:
-24.43%
1M Prestazione:
-2.36%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.3724
$0.4098
Intervallo di 1 settimana:
$0.3724
$0.4617
Portata 52W:
$0.1513
$1.66
Lunai Bioworks Inc Stock (LNAI) Company Profile
Nome
Lunai Bioworks Inc
Settore
Industria
Telefono
45 39179840
Indirizzo
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare LNAI vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNAI
Lunai Bioworks Inc
|
0.373 | 9.02M | 0 | -125.52M | -5.72M | -7.5468 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Lunai Bioworks Inc Borsa (LNAI) Ultime notizie
Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M - MSN
Lunai Bioworks (NASDAQ: LNAI) asks shareholders to approve up to 1‑for‑30 reverse split - Stock Titan
Lunai Bioworks Inc (2Q50.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Lunai Bioworks Inc Com (LNAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Lunai Bioworks Expands CNS Portfolio With $20M Acquisition - TipRanks
Lunai Bioworks Unveils $20M Preferred Investment and Debt-for-Equity Exchange to Advance CNS Assets - TradingView
Lunai Bioworks (NASDAQ: LNAI) secures $20M CNS Alzheimer’s deal and converts secured debt - Stock Titan
Lunai Bioworks completes $20M transaction to acquire BBB - MSN
Lunai Bioworks acquires CNS drug delivery tech for $20M By Investing.com - ca.investing.com
LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) - ChartMill
Why did LNAI stock skyrocket over 130% pre-market today? - MSN
Microcap March Madness: LNAI, FAGI, VSA, LNKS Sweet 16 Underdog Watch - Barchart
Lunai Bioworks Acquires $20M in BBB Delivery Tech, CNS Alzheimer’s Assets from Clemann Group - Contract Pharma
Why did LNAI stock skyrocket over 130% pre-market today? | Tap to know more | Inshorts - Inshorts
Lunai Bioworks, Inc. (LNAI) Stock: No-Reset Convertible Deal Boosts CNS Drug Development Edge - parameter.io
What's Behind The Jump In Lunai Bioworks Stock? - Benzinga
Lunai Bioworks (LNAI) Acquires BBB Technology in $20M Deal - GuruFocus
Why Did LNAI Stock Surge Over 25% Today? - Stocktwits
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications - Finviz
LNAI Enhances CNS Pipeline with Strategic Acquisition - GuruFocus
Why Did LNAI Stock Skyrocket Over 130% Pre-Market Today? - stocktwits.com
Lunai Bioworks acquires CNS drug delivery tech for $20M - Investing.com
Lunai Bioworks Executes $20M Strategic Transaction At Fixed $1.50 Conversion, Acquiring Bbb Delivery Platform For Cns Alzheimer's Therapies With Broad Cns Delivery Applications - TradingView
Lunai Bioworks Inc. has executed binding agreement to acquire BBB delivery technology and CNS Alzheimer's drug assets of Clemann Group from Clemann Group for $20 million. - MarketScreener
If You Invested $1,000 in Renovaro (RENB) - Stock Titan
$400M to $1.2 Billion US Countermeasures Program Presents Huge Opportunity for New AI Platform to Meet Emerging Battlefield and Terrorism Threats: Lunai Bioworks (Nasdaq: LNAI) - Barchart.com
$400M to $1.2 Billion US Countermeasures Program Presents Huge - openPR.com
Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI) - PRLog
Lunai Bioworks Engages Initial U.S. Countermeasure Opportunities Following $400M–$1.2B Consortium Launch - weeklyvoice.com
Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model - Finviz
LNAI Initiates Consortium to Speed Up Chemical Countermeasure De - GuruFocus
Lunai Bioworks (LNAI) Stock Forecast and Price Target 2026 $LNAI - MarketBeat
LNAI stock: Lunai Bioworks (NASDAQ) $0.52, vol 509,735,274 on 17 Mar 2026: monitor AI oncology signals - Meyka
Why Is This Micro-Cap Biotech Stock Up 150% Today? - Stocktwits
Best Manufacturing Stocks To Watch TodayMarch 17th - MarketBeat
Why Is LNAI Stock Skyrocketing Today? - Stocktwits
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Lunai Bioworks (LNAI) jumps 189% as traders refocus on recent IP update and looming Nasdaq listing decision - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's Pre-Market SessionAldeyra Therapeutics (NASDAQ:ALDX), Agape - Benzinga
Lunai Launches AI Safeguard Sentinel to Prevent Chemical Agent Generation - Intellectia AI
ENOB FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class ActionENOB - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday SessionFirefly Neuroscience (NASDAQ:AIFF), AN2 Thera - Benzinga
Lunai Bioworks initiates employee furloughs and salary deferrals to preserve liquidity - Investing.com UK
Lunai Bioworks Furloughs Staff Amid Liquidity Constraints - TipRanks
Lunai Bioworks implements temporary furlough of employees in US and CanadaSEC filing - marketscreener.com
Lunai Bioworks implements temporary furloughs, execs defer salaries to preserve liquidity - TradingView
Financial Survey: Lunai Bioworks (NASDAQ:LNAI) versus Lite Strategy (NASDAQ:LITS) - Defense World
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - The Sheboygan Press
Lunai Bioworks Highlights Sentinel AI Safeguard After Anthropic CEO Warning on AI Chemical and Biological Threats - The Destin Log
LNAI Should I Buy - Intellectia AI
Lunai Bioworks Inc Azioni (LNAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):